Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-04-05

FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Sevelamer carbonate by Aurobindo Pharma Limited. This approval enables the generic product to be marketed under ANDA…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SEVELAMER CARBONATE (sevelamer carbonate)

Snippet

SUPPL AP for SEVELAMER CARBONATE (SEVELAMER CARBONATE)